LOKELMA 5 GM Powder for Oral Suspension

DRUG2 trials

Sponsors

Steno Diabetes Center Copenhagen, NephroNet, Inc.

Conditions

HyperkalemiaType 2 Diabetes Mellitus With Kidney Complications

Phase 4

The Effect of Sodium Zirconium Cyclosilicate on Albuminuria in Patients With Type 2 Diabetes and Hyperkalemia

Steno Diabetes Center CopenhagenType 2 Diabetes Mellitus With Kidney Complications

Start: 2019-10-31End: 2021-12-31Target: 20Updated: 2019-10-16

A Prospective, Randomized, Open-Label, Cross-Over Study of Lokelma to Control Interdialytic Hyperkalemia

CompletedNCT05535920

NephroNet, Inc.Hyperkalemia

Start: 2022-04-14End: 2024-04-01Updated: 2024-06-05